Chronic sleep deprivation and elevated cortisol levels may impact fat metabolism and appetite regulation
Ozempic pens are designed for exactly four weekly doses at the prescribed strength
Our semaglutide weight loss programs are designed for patients seeking medically supervised support for appetite control and fat reduction
Long acting GLP-1RAs (eg, liraglutide, exenatide, and dulaglutide) have more profound effects on nocturnal and fasting glucose and glycated haemoglobin (HbA 1c ), both in the context of oral hypoglycaemic drugs and in combination with basal insulin
A phase 2 trial published in the New England Journal of Medicine showed average weight loss of over 24% at 48 weeks, and the first phase 3 results in December 2025 suggested that average weight loss could be around 28 to 29%
Nearly half of those, 181, involve the tirzepatide-based drug sold as Mounjaro